Patients With Lung, Breast, Head and Neck, or Pelvic Malignancies
Conditions
Brief summary
The goals of this study are to assess the feasibility of weekly administration of site specific patient reported assessments using an electronic platform and to explore the correlation between patient reported outcomes as well as known dosimetric prognostic factors in patients with lung, breast, head and neck, or pelvic malignancies
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients with breast cancer, lung cancer, head and neck cancer, or gynecologic cancer receiving definitive external beam radiotherapy. * Must be ≥ 18 years of age * Able to read, write, and speak English in order to complete patient reported outcomes. Patients will be approached about the study at the time of consultation or at the time of simulation by their treating physicians or by a research coordinator. All patients must sign a study-specific informed consent to participate. All patients, including those who do not choose to consent to the study, will be provided with a short survey to assess health literacy using the eHealth Literacy Scale (eHEALS). For those not consenting to the study, the survey will be de-identified and will also ask for basic demographic information including age grouping, race, education level, and type of cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of Surveys completed | five years |
Countries
United States